Ambassador Zara Bayla Juan's Peace Formula: "Wellness in Mind, Body, Spirit, Environment and Economics for Peace and Nation Building". The Philippine Contribution to United Nations International Day of Peace and United Nations Climate Change Adaptation Worldwide
Extent of Coverage as of Today
Translate
Wednesday, May 24, 2023
Watch! #WED Wellness Tip at Shangrila Manila May 20, 2023. WED is Wellness in Environment Day TV show by AmbZara Jane Juan copyrighted 2010-2023
Friday, March 17, 2023
#WED fCAT TVshow by AmbZara Peace Innovation Invite to UN SDG Investment Fair April 2023. Free Registration online. Register Now!
Wellness Pilipinas International News and Media Network #invite #online #announcement from United Nations
Department of Economic and Social Affairs
π₯SDGI Fair 2023
SDG Investment Fair 2023 - Register Today!π₯
π₯SDG Investment Projects Pitched to Investorsπ₯
What is the SDG Investment Fair?
Launched in 2018, the Fair has become a leading platform to facilitate dealmaking in SDG investment, with over US$11 billion worth of projects in infrastructure, green energy, and agribusiness presented so far. Now in its 8th edition, twenty countries across all regions have been showcased as SDG investment destinations.
π₯Hosted by the Financing for Sustainable Development Office of the United Nations Department of Economic and Social Affairs, the Fair facilitates a range of investment promotion activities in New York City, as well as capacity building at the national level to enhance the investment readiness and bankability of projects and SDG financing vehicles in participating countries.
π₯The Fair supports countries with the preparation, structuring, and mapping of countries' priority SDG investment projects through workshops, technical assistance, and capacity-building tools.
“The SDG Investment Fair … has helped the Kenyan Government to showcase priority investment opportunities in Kenya across multiple sectors to a global audience of investors, financiers and technical experts,” said Stephen Jackson, UN Resident Coordinator in Kenya after participating in the Fair.
π₯The Fair in Numbers
11 billion USD worth of project investments.
7 SDG Investment Fairs held since 2018.
22 countries showcased.
~5k key actors engaged in the SDG financing network.
Benefits for Participating Countries:
Access a ‘one-stop-shop’ platform for brokering investments and knowledge:
The Fair offers space to pitch investment projects, one-on-one investor exchanges, knowledge sharing, and technical assistance.
π₯Network with investors and other key players:
Tap into the wider network of banks, investors, development agencies, and advisory partners, including members of the Global Investors for Sustainable Development (GISD) Alliance.
Place your country’s investment opportunities on the map:
Raise awareness of investment opportunities to a growing pool of investors seeking opportunities to make a positive impact, mitigate systemic risks, and meaningfully contribute to achieving the SDGs.
To join the event in April 2023, please register here:
https://www.cognitoforms.com/NellyRitaMakena/April2023SDGInvestmentFair
Registration deadline: March 31, 2023
ππππππππ
Wellness for Peace Education on Climate Change Peace Innovation: fcat of Amb. Juan sailing for peace AmbassadorZara JaneBayla Juan #PEACEVIGIL2023 #fCAT food culture arts and technology #WED Wellness in Environment Day TV show copyrighted 2010-2023. All Rights Reserved.
Saturday, July 11, 2020
#MedicalResearch on #Obesity: Study pinpoints brain cells that trigger sugar cravings and consumption
"The new study, led by Matthew Potthoff, Ph.D., associate professor of neuroscience and pharmacology in the University of Iowa Carver College of Medicine, and Matthew Gillum, Ph.D., at the University of Copenhagen in Denmark, focuses on actions of a hormone called fibroblast growth factor 21 (FGF21). This hormone is known to play a role in energy balance, body weight control, and insulin sensitivity.
"This is the first study that's really identified where this hormone is acting in the brain and that has provided some very cool insights to how it's regulating sugar intake," says Potthoff, who also is a member of the Fraternal Order of Eagles Diabetes Research Center at the UI and the Iowa Neuroscience Institute.
Potthoff and his colleagues previously discovered that FGF21 is made in the liver in response to increased levels of sugar, and acts in the brain to suppress sugar intake and the preference for sweet taste.
Building on that finding, the team has now shown, for the first time, which brain cells respond to FGF21's signals and how that interaction helps regulate sugar intake and sweet taste preference. The study, published in the journal Cell Metabolism, also reveals how the hormone mediates its effects.
Although it was known that FGF21 acted in the brain, identifying the exact cellular targets was complicated by the fact that the hormone's receptor is expressed at very low levels and is therefore difficult to "see." Using various techniques, the researchers were able to precisely identify which cells express the receptor for FGF21. By investigating these cells, the study shows that FGF21 targets glutamatergic neurons in the brain to lower sugar intake and sweet taste preference. The researchers also showed that FGF21's action on specific neurons in the ventromedial hypothalamus reduce sugar intake by enhancing the neurons' sensitivity to glucose.
Several drugs based on a modified form of FGF21 are already being tested as treatments for obesity and diabetes. The new findings could potentially lead to new drugs that more precisely target the different behaviors controlled by FGF21, which might help to control how much sugar a person eats."
For study reference source:
https://medicalxpress.com/news/2020-07-brain-cells-trigger-sugar-cravings.html
Sunday, June 28, 2020
UN calling for recovery plans to be built around low-carbon technologies
Thursday, February 20, 2020
Thursday, November 14, 2019
WHO launches first-ever insulin prequalification programme to expand access to life-saving treatment for diabetes
The World Health Organization (WHO) announced 13 November 2019
the start of a pilot programme to prequalify human insulin to increase treatment for diabetes in low- and middle-income countries.
The decision, announced ahead of World Diabetes Day (14 November), is part of a series of steps WHO will take to address the growing diabetes burden in all regions. About 65 million people with type 2 diabetes need insulin, but only half of them are able to access it, largely due to high prices. All people with type 1 diabetes need insulin to survive.
“Diabetes is on the rise globally, and rising faster in low-income countries,” says Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “Too many people who need insulin encounter financial hardship in accessing it, or go without it and risk their lives. WHO’s prequalification initiative for insulin is a vital step towards ensuring everyone who needs this life-saving product can access it.”
Insulin prequalification can lead to lower prices
WHO prequalification of insulin is expected to boost access by increasing the flow of quality-assured products on the international market, providing countries with greater choice and patients with lower prices.
Insulin was discovered as a treatment for diabetes almost 100 years ago and has been on WHO’s List of Essential Medicines since it was published in 1977.
Despite an ample supply, insulin prices are currently a barrier to treatment in most low- and middle-income countries. Three manufacturers control most of the global market for insulin, setting prices that are prohibitive for many people and countries.
Access to insulin a challenge in many countries
Data collected by WHO in 2016-2019 from 24 countries on four continents showed that human insulin was available only in 61% of health facilities and analogue insulins in 13%. The data showed that a month’s supply of insulin would cost a worker in Accra, Ghana, the equivalent of 5.5 days of pay per month, or 22% of his/her earnings.
In wealthy countries, people often have to ration insulin, which can be deadly for people who do not get the right quantity of the medicine.
“Prequalifying products from additional companies will hopefully help to level the playing field and ensure a steadier supply of quality insulin in all countries,” says Dr MariΓ’ngela SimΓ£o, Assistant Director General for Medicines and Health products.
More than 420 million people live with diabetes. Diabetes is the seventh leading cause of death and a major cause of costly and debilitating complications such as heart attacks, stroke, kidney failure, blindness and lower limb amputations.
People with type 1 diabetes need insulin for survival and to maintain their blood glucose at levels to reduce the risk of common complications such as blindness and kidney failure. People with type 2 diabetes need insulin for controlling blood glucose levels to avoid complications when oral medicines become less effective as the illness progresses.
Insulin prequalification is one of a number of steps WHO will take in the coming year to address the diabetes burden. Plans are underway to update diabetes treatment guidelines, devise price reduction strategies for analogues and improve delivery systems and access to diagnostics. WHO also works with countries to promote healthier diets and physical activity to lower people’s risk of developing type 2 diabetes.
Note to editors
The WHO Prequalification of Medicines Programme contributes to accelerating and increasing access to critical medical products that are quality-assured, affordable and adapted for markets in low- and middle-income countries.
The programme does this by evaluating medical products developed by manufacturers to ensure their quality, safety and efficacy, in turn expanding the pool of available quality medicines.
Evaluating and prequalifying health products then guides international procurement agencies, such as the Global Fund, Gavi, the Vaccine Alliance, and UNICEF, and increasingly countries to make bulk purchases of medicines vaccines, diagnostics and other critical products at lower prices.
Sailing for Peace Coffee Talk
Search This Blog
Blog Archive
- ► 2011 (534)